Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.24.1.1.u2
Stockholders’ Equity (Tables)
3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Schedule of Stock Options Activity
The following table summarizes stock option activity during the three months ended March 31, 2024, (in thousands, except per share data).
Number of Shares Weighted Average Exercise Price  Weighted Average Remaining Contractual Life
(in years)
Total Intrinsic Value
Outstanding as of January 1, 2024 2,951 $ 7.30  4.8 $ 693 
Granted 1,790 6.00  7.0 — 
Forfeited (289) 8.81  —  — 
Outstanding as of March 31, 2024 4,452 $ 6.68  5.6 3,012 
Options vested and exercisable 2,235 $ 6.43  4.7 2,290 
Schedule of Weighted Average Assumptions Used in Determining Fair Value of Options
The following table summarizes weighted average assumptions used in determining the fair value of the stock options at the date of grant during the three months ended March 31, 2024 and 2023:
For the three months ended
March 31, 2024 March 31, 2023
Exercise price $ 6.00  $ 6.84 
Expected term (years) 4.5 4.3
Expected stock price volatility 79.6  % 80.9  %
Risk-free rate of interest 4.2  % 3.8  %
Expected dividend yield (per share) % %
Schedule of Warrant Activity
The following table summarizes warrant activity during the three months ended March 31, 2024 (in thousands, except per share data):
Number of Shares Weighted Average Exercise
Price
Weighted Average
Remaining Contractual Life
 (in years)
Outstanding as of January 1, 2024 831 $ 11.16  1.9
Forfeited (455) 12.83
Outstanding as of March 31, 2024 376 $ 9.13  3.9
Warrants vested and exercisable 376 $ 9.13  3.9